Agenus Reports First Quarter 2024 ResultsBusiness Wire • 5 days agoAgenus Inc. (Agenus) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced results for the first quarter 2024. In a concurrent...